Back to Newsroom

Boston Business Journal: Norwood biotech’s shares soar on FDA news that could speed up drug approval

Don Seiffert

Aug 19, 2015

Shares of Corbus Pharmaceuticals rose more than 50 percent today after the Norwood company announced that it got a designation from the FDA that could speed up the trial process for a drug to treat the “most lethal of the systemic autoimmune diseases,” according to the CEO.